Sign Up
SB 2050 Hawaii Senate · 2020 Regular Session

RELATING TO INDUSTRIAL HEMP DERIVED PRODUCTS.

Summary
Establishes a regulatory framework for products containing cannabidiol that were manufactured legally through approved government programs. Clarifies that these products are not considered adulterated food, beverage, or cosmetic products. Prohibits manufacturers from making health-related claims. Requires product labeling for the products to be legally allowed in the State. Exempts industrial hemp products that are generally recognized as safe by the Food and Drug Administration from the new regulatory framework. Effective 7/31/2150. (HD1)
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2020
Committee Review
Mar 2020
Senate Passage
Mar 2020
House Passage
Governor
Introduced Jan 16, 2020 Last action Mar 16, 2020
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
23
Key actions
7
Committee
12
Mar 13, 2020
Committee
Reported from AGR (Stand. Com. Rep. No. 1034-20) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
lower
Mar 12, 2020
Committee
Re-referred to AGR, CPC, FIN, referral sheet 41
lower
Mar 11, 2020
Lower · Passed
The committees on AGR recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 6 Ayes: Representative(s) Creagan, DeCoite, Cabanilla Arakawa, Onishi, Perruso, Thielen; Ayes with reservations: none; 0 Noes: none; and 2 Excused: Representative(s) Cachola, Holt.
lower
Mar 9, 2020
Committee
Referred to AGR, JUD, FIN, referral sheet 36
lower
Mar 3, 2020
Introduced
Received from Senate (Sen. Com. No. 97) in amended form (SD 2).
lower
Mar 3, 2020
Upper · Passed
Report Adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: Senator(s) Harimoto, Kim, Riviere, Ruderman, L. Thielen. Noes, 0 (none). Excused, 0 (none). Transmitted to House.
upper
Feb 21, 2020
Upper · Passed
The committee(s) on JDC recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in JDC were as follows: 3 Aye(s): Senator(s) K. Rhoads, J.Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Gabbard, Kim.
upper
Feb 21, 2020
Upper · Passed
The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 4 Aye(s): Senator(s) Baker, Nishihara, Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 3 Excused: Senator(s) S. Chang, Ruderman, L. Thielen.
upper
Feb 14, 2020
Upper · Passed
The committee(s) on CPH/JDC will hold a public decision making on 02-21-20 10:30AM in conference room 229.
upper
Feb 13, 2020
Committee
Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPH/JDC.
upper
Feb 13, 2020
Committee
Reported from AEN (Stand. Com. Rep. No. 2656) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPH/JDC.
upper
Feb 10, 2020
Upper · Passed
The committee(s) on AEN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in AEN were as follows: 3 Aye(s): Senator(s) Gabbard; Aye(s) with reservations: Senator(s) Ruderman, L. Thielen ; 0 No(es): none; and 2 Excused: Senator(s) K. Rhoads, Fevella.
upper
Jan 30, 2020
Upper · Passed
The committee(s) on AEN has scheduled a public hearing on 02-10-20 2:20PM in conference room 224.
upper
Jan 17, 2020
Committee
Referred to AEN, CPH/JDC.
upper
Jan 16, 2020
Introduced
Introduced.
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.